Review




Structured Review

BIOTAGE hsq96 pyrosequencer
Hsq96 Pyrosequencer, supplied by BIOTAGE, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing+pyrosequencer/hsq96+pyrosequencer/pmc04186640-27-18-20
Average 90 stars, based on 1 article reviews
hsq96 pyrosequencer - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Mutagenesis:

Article Title: Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Article Snippet: This is a PDF file of an unedited peer-reviewed manuscript that has been accepted for publication.. NPG are providing this early version of the manuscript as a service to our customers.. The manuscript will undergo copyediting, typesetting and a proof review before it is published in its final form.

Article Title: Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors
Article Snippet: .. 3 On follow-up samples, the ratio of F317L mutated to unmutated transcripts was performed by pyrosequencing using an HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden), following a similar nested PCR approach with a sensitivity of 1% to 5% mutation-bearing BCR-ABL transcripts. ..

Isolation:

Article Title: Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Article Snippet: This is a PDF file of an unedited peer-reviewed manuscript that has been accepted for publication.. NPG are providing this early version of the manuscript as a service to our customers.. The manuscript will undergo copyediting, typesetting and a proof review before it is published in its final form.

Article Title: Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy
Article Snippet: For analysis of T315I in follow-up samples, pyrosequencing was performed following this first-round PCR. .. PCR was performed using one biotin-tagged primer, with single-stranded PCR product isolated on strepavidin-sepharose beads (GE Healthcare, Little Chalfont, United Kingdom) and sequenced using nucleotide dispensation tips and Pyro Gold reagents on a HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden). .. The sensitivity of pyrosequencing was 1% to 5% mutation-bearing BCR-ABL transcripts, depending on the initial levels of fusion transcript.

Article Title: Kinase Domain Point Mutations in Ph+ Acute Lymphoblastic Leukemia (ALL) Emerge Following Therapy with BCR-ABL Kinase Inhibitors
Article Snippet: For mutation analysis of codons 311-317 and codons 250-255, pyrosequencing was performed following first round PCR, as above and different 2 nd -round PCR reactions. .. Second round PCR was performed using one biotin-tagged primer and single-stranded product isolated by avidin-sepharose beads (GE Life Sciences, Piscataway, NJ) and sequenced using a HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden). .. Second round PCR was performed using one biotin-tagged primer and single-stranded product isolated by avidin-sepharose beads (GE Life Sciences, Piscataway, NJ) and sequenced using a HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden).

Article Title: Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era.
Article Snippet: Funding information National Institutes of Health; MD Anderson's Cancer Center Leukemia SPORE, Grant/Award Number: CA100632; Cancer Center Support Grant (CCSG), Grant/Award Number: P30CA016672; Charif Souki Cancer Research Grant Abstract Patients with chronic myeloid leukemia (CML) and T315I mutation generally have a poor prognosis.. Their outcome in the post-ponatinib era remains unclear.. We reviewed patients with CML in chronic (CP) or accelerated phase (AP) who developed a T315I mutation between March 15, 2004, and July 26, 2022.

Article Title: Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era
Article Snippet: For analysis of T315I in follow-up samples, pyrosequencing was performed following this first-round PCR. .. PCR was performed using one biotin-tagged primer, with single-stranded PCR product isolated on strepavidin-sepharose beads (GE Healthcare, Little Chalfont, United Kingdom) and sequenced using nucleotide dispensation tips and Pyro Gold reagents on a HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden). .. The sensitivity of pyrosequencing was 1% to 5% mutation-bearing BCR::ABL1 transcripts, depending on the initial levels of fusion transcript.

Article Title: Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations
Article Snippet: For analysis of follow-up samples, pyrosequencing was performed after first-round PCR (as mentioned earlier in this paragraph). .. PCR was performed using one biotin-tagged primers, single-stranded PCR product isolated on strepavidin sepharose beads (GE Healthcare), and sequenced using nucleotide dispensation tips and Pyro Gold reagents on a HSQ96 Pyrosequencer (Biotage). .. The sensitivity of the pyrosequencing was 1% to 5% mutation-bearing transcripts depending on the initial levels of fusion transcript.

Avidin-Biotin Assay:

Article Title: Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Article Snippet: This is a PDF file of an unedited peer-reviewed manuscript that has been accepted for publication.. NPG are providing this early version of the manuscript as a service to our customers.. The manuscript will undergo copyediting, typesetting and a proof review before it is published in its final form.

Article Title: Kinase Domain Point Mutations in Ph+ Acute Lymphoblastic Leukemia (ALL) Emerge Following Therapy with BCR-ABL Kinase Inhibitors
Article Snippet: For mutation analysis of codons 311-317 and codons 250-255, pyrosequencing was performed following first round PCR, as above and different 2 nd -round PCR reactions. .. Second round PCR was performed using one biotin-tagged primer and single-stranded product isolated by avidin-sepharose beads (GE Life Sciences, Piscataway, NJ) and sequenced using a HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden). .. Second round PCR was performed using one biotin-tagged primer and single-stranded product isolated by avidin-sepharose beads (GE Life Sciences, Piscataway, NJ) and sequenced using a HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden).

Polymerase Chain Reaction:

Article Title: Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy
Article Snippet: For analysis of T315I in follow-up samples, pyrosequencing was performed following this first-round PCR. .. PCR was performed using one biotin-tagged primer, with single-stranded PCR product isolated on strepavidin-sepharose beads (GE Healthcare, Little Chalfont, United Kingdom) and sequenced using nucleotide dispensation tips and Pyro Gold reagents on a HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden). .. The sensitivity of pyrosequencing was 1% to 5% mutation-bearing BCR-ABL transcripts, depending on the initial levels of fusion transcript.

Article Title: Kinase Domain Point Mutations in Ph+ Acute Lymphoblastic Leukemia (ALL) Emerge Following Therapy with BCR-ABL Kinase Inhibitors
Article Snippet: For mutation analysis of codons 311-317 and codons 250-255, pyrosequencing was performed following first round PCR, as above and different 2 nd -round PCR reactions. .. Second round PCR was performed using one biotin-tagged primer and single-stranded product isolated by avidin-sepharose beads (GE Life Sciences, Piscataway, NJ) and sequenced using a HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden). .. Second round PCR was performed using one biotin-tagged primer and single-stranded product isolated by avidin-sepharose beads (GE Life Sciences, Piscataway, NJ) and sequenced using a HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden).

Article Title: Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era.
Article Snippet: Funding information National Institutes of Health; MD Anderson's Cancer Center Leukemia SPORE, Grant/Award Number: CA100632; Cancer Center Support Grant (CCSG), Grant/Award Number: P30CA016672; Charif Souki Cancer Research Grant Abstract Patients with chronic myeloid leukemia (CML) and T315I mutation generally have a poor prognosis.. Their outcome in the post-ponatinib era remains unclear.. We reviewed patients with CML in chronic (CP) or accelerated phase (AP) who developed a T315I mutation between March 15, 2004, and July 26, 2022.

Article Title: Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre- and post-ponatinib era
Article Snippet: For analysis of T315I in follow-up samples, pyrosequencing was performed following this first-round PCR. .. PCR was performed using one biotin-tagged primer, with single-stranded PCR product isolated on strepavidin-sepharose beads (GE Healthcare, Little Chalfont, United Kingdom) and sequenced using nucleotide dispensation tips and Pyro Gold reagents on a HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden). .. The sensitivity of pyrosequencing was 1% to 5% mutation-bearing BCR::ABL1 transcripts, depending on the initial levels of fusion transcript.

Article Title: Long-term outcome of patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations
Article Snippet: For analysis of follow-up samples, pyrosequencing was performed after first-round PCR (as mentioned earlier in this paragraph). .. PCR was performed using one biotin-tagged primers, single-stranded PCR product isolated on strepavidin sepharose beads (GE Healthcare), and sequenced using nucleotide dispensation tips and Pyro Gold reagents on a HSQ96 Pyrosequencer (Biotage). .. The sensitivity of the pyrosequencing was 1% to 5% mutation-bearing transcripts depending on the initial levels of fusion transcript.

other:

Article Title: Stem cell transplantation for patients with chronic myeloid leukemia resistant to tyrosine kinase inhibitors with BCR-ABL kinase domain mutation T315I.
Article Snippet: Quantification of the T315I mutation was performed by pyrosequencing with a similar nested PCR approach (HSQ96 Pyrosequencer; Biotage, Uppsala, Sweden) with a sensitivity of 1% to 5% mutation-bearing BCR-ABL transcripts.5 Engraftment was defined as the first of 3 consecutive days with an absolute neutrophil count >0.5 109/L.

Nested PCR:

Article Title: Characteristics and outcome of chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors
Article Snippet: .. 3 On follow-up samples, the ratio of F317L mutated to unmutated transcripts was performed by pyrosequencing using an HSQ96 Pyrosequencer (Biotage, Uppsala, Sweden), following a similar nested PCR approach with a sensitivity of 1% to 5% mutation-bearing BCR-ABL transcripts. ..



Similar Products

86
Pyrosequencing Inc genusspecific amplicon pyrosequencing
Genusspecific Amplicon Pyrosequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing+pyrosequencer/amplicon+genusspecific+pyrosequencing/pm42321336-560-6-8
Average 86 stars, based on 1 article reviews
genusspecific amplicon pyrosequencing - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Pyrosequencing Inc dna pyrosequencing methylation assays
Dna Pyrosequencing Methylation Assays, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing+pyrosequencer/analysis+methylation+pyrosequencing+quantitative+universal/us12655484-167-3-4
Average 86 stars, based on 1 article reviews
dna pyrosequencing methylation assays - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Pyrosequencing Inc dna pyrosequencing
Dna Pyrosequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing+pyrosequencer/bisulfite+pyrosequencing/us12655484-175-11-12
Average 86 stars, based on 1 article reviews
dna pyrosequencing - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Pyrosequencing Inc 454 picotiter pyrosequencing technology
454 Picotiter Pyrosequencing Technology, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing+pyrosequencer/454+picotiter+pyrosequencing+technology/us12649920-222-11-13
Average 86 stars, based on 1 article reviews
454 picotiter pyrosequencing technology - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Pyrosequencing Inc bisulfite pyrosequencing
Bisulfite Pyrosequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing+pyrosequencer/bisulfite+pyrosequencing/pmc13054102-148-5-6
Average 86 stars, based on 1 article reviews
bisulfite pyrosequencing - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Pyrosequencing Inc pyrosequencing based analysis
Pyrosequencing Based Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing+pyrosequencer/16s+pyrosequencing+rrna/pm42128334-658-12-12
Average 86 stars, based on 1 article reviews
pyrosequencing based analysis - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Pyrosequencing Inc 454 pyrosequencing analysis
454 Pyrosequencing Analysis, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing+pyrosequencer/454+pyrosequencing/pm42114637-806-14-14
Average 86 stars, based on 1 article reviews
454 pyrosequencing analysis - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Pyrosequencing Inc 16s rrna pyrosequencing technology
16s Rrna Pyrosequencing Technology, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing+pyrosequencer/16s+pyrosequencing+rrna/pm42106047-506-0-2
Average 86 stars, based on 1 article reviews
16s rrna pyrosequencing technology - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Pyrosequencing Inc 16s rrna pyrosequencing
16s Rrna Pyrosequencing, supplied by Pyrosequencing Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pyrosequencing+pyrosequencer/16s+pyrosequencing+rrna/pmc13113534-164-11-13
Average 86 stars, based on 1 article reviews
16s rrna pyrosequencing - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results